These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24412678)

  • 21. A gene expression pattern in blood for the early detection of Alzheimer's disease.
    Booij BB; Lindahl T; Wetterberg P; Skaane NV; Sæbø S; Feten G; Rye PD; Kristiansen LI; Hagen N; Jensen M; Bårdsen K; Winblad B; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):109-19. PubMed ID: 20930264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of Alzheimer's disease-associated CD33 results in an inflammatory human microglia phenotype.
    Wißfeld J; Nozaki I; Mathews M; Raschka T; Ebeling C; Hornung V; Brüstle O; Neumann H
    Glia; 2021 Jun; 69(6):1393-1412. PubMed ID: 33539598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
    Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
    J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
    Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
    Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodology for discovery of Alzheimer's disease blood-based biomarkers.
    Maes OC; Schipper HM; Chertkow HM; Wang E
    J Gerontol A Biol Sci Med Sci; 2009 Jun; 64(6):636-45. PubMed ID: 19366883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
    Jia LH; Liu YN
    Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
    Tan M; Wang S; Song J; Jia J
    Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Delbarba A; Abate G; Prandelli C; Marziano M; Buizza L; Arce Varas N; Novelli A; Cuetos F; Martinez C; Lanni C; Memo M; Uberti D
    Oxid Med Cell Longev; 2016; 2016():5923938. PubMed ID: 26881032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
    Estus S; Shaw BC; Devanney N; Katsumata Y; Press EE; Fardo DW
    Acta Neuropathol; 2019 Aug; 138(2):187-199. PubMed ID: 30949760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders.
    Wang YJ; Wan Y; Wang HF; Tan CC; Li JQ; Yu JT; Tan L;
    J Alzheimers Dis; 2019; 68(2):757-766. PubMed ID: 30883353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric testing for paroxysmal nocturnal hemoglobinuria: CD64 is better for gating monocytes than CD33.
    Dalal BI; Khare NS
    Cytometry B Clin Cytom; 2013; 84(1):33-6. PubMed ID: 23018985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased plasma antioxidants in patients with Alzheimer's disease.
    Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients.
    Reale M; Iarlori C; Gambi F; Feliciani C; Isabella L; Gambi D
    Neuropharmacology; 2006 Apr; 50(5):606-13. PubMed ID: 16445950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral markers of Alzheimer's disease: surveillance of white blood cells.
    Shad KF; Aghazadeh Y; Ahmad S; Kress B
    Synapse; 2013 Aug; 67(8):541-3. PubMed ID: 23404438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformationally altered p53: a novel Alzheimer's disease marker?
    Lanni C; Racchi M; Mazzini G; Ranzenigo A; Polotti R; Sinforiani E; Olivari L; Barcikowska M; Styczynska M; Kuznicki J; Szybinska A; Govoni S; Memo M; Uberti D
    Mol Psychiatry; 2008 Jun; 13(6):641-7. PubMed ID: 17684496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid levels in patients with Alzheimer's disease.
    Presećki P; Mück-Seler D; Mimica N; Pivac N; Mustapić M; Stipcević T; Smalc VF
    Coll Antropol; 2011 Jan; 35 Suppl 1():115-20. PubMed ID: 21648320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.
    Grünblatt E; Bartl J; Zehetmayer S; Ringel TM; Bauer P; Riederer P; Jacob CP
    J Alzheimers Dis; 2009; 16(3):627-34. PubMed ID: 19276557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma endothelial microparticles in Alzheimer's disease.
    Xue S; Cai X; Li W; Zhang Z; Dong W; Hui G
    Dement Geriatr Cogn Disord; 2012; 34(3-4):174-80. PubMed ID: 23075931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease.
    Tacconi S; Perri R; Balestrieri E; Grelli S; Bernardini S; Annichiarico R; Mastino A; Caltagirone C; Macchi B
    Exp Neurol; 2004 Nov; 190(1):254-62. PubMed ID: 15473998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.